We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laparoscopy Benefits Last Longer Than Expected

By HospiMedica International staff writers
Posted on 03 May 2012
A new study has found that minimally invasive abdominal and pelvic laparoscopy correlated with fewer incidents of small-bowel obstruction (SBO) over time.

Researchers at the University of Gothenburg (Sweden) and the Swedish National Board of Health and Welfare (Socialstyrelsen; Stockholm) conducted a population-based retrospective study involving 108,141 inpatients registered by the Socialstyrelsen, to inspect the incidence and risk factors for SBO. More...
The researchers identified demographic characteristics, comorbidity, previous abdominal surgery, and death data for several procedures, including cholecystectomy, hysterectomy, bowel resection, anterior resection, rectopexy, appendectomy, and bariatric surgery. The main outcome measures were episodes of hospital stay and surgery for SBO within five years after the surgery.

The results showed that the incidence of SBO ranged from 0.4%-13.9%, and open surgery seems to increase the risk of SBO at least 4 times compared with laparoscopy for most of the abdominal surgical procedures studied. Multivariate analysis revealed age, previous surgery, comorbidity, and surgical technique to be risk factors for SBO; laparoscopy exceeded other risk factors in reduction of the risk of SBO for most of the surgical procedures. The study was published in the April 2012 issue of Archives of Surgery.

“Of the possible factors to examine in a population-based registry, our study identified the surgical technique, open versus laparoscopic, to be one of the more important for the risk of SBO,” concluded lead author Eva Angenete, MD, PhD, and colleagues. “Adhesion-related morbidity is related to substantial health care costs and, as a complication of surgery, it is becoming a medico-legal issue. Reduction of adhesion-related morbidity, such as SBO, is thus of importance for patients as well as for society.”

The leading cause of SBO in industrialized countries is postoperative adhesions (60%). Surgeries most closely associated with SBO are appendectomy, colorectal surgery, and gynecologic and upper gastrointestinal (GI) procedures. SBOs can be partial or complete, simple or strangulated. If not diagnosed and properly treated, vascular compromise leads to bowel ischemia and further morbidity and mortality. Because as many as 40% of patients have strangulated obstructions, SBO accounts for 20% of all acute surgical admissions.

Related Links:

University of Gothenburg
Swedish National Board of Health and Welfare



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.